| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 34.920 | 77.016 | 70.158 | 63.182 | 73.506 | 68.521 | 53.293 | 37.417 | 12.254 |
| Total Income - EUR | - | 34.923 | 77.017 | 70.159 | 63.432 | 73.621 | 68.798 | 65.418 | 37.556 | 12.277 |
| Total Expenses - EUR | - | 35.318 | 75.457 | 74.388 | 66.004 | 75.011 | 71.130 | 64.678 | 40.560 | 14.952 |
| Gross Profit/Loss - EUR | - | -396 | 1.560 | -4.229 | -2.572 | -1.391 | -2.332 | 740 | -3.004 | -2.675 |
| Net Profit/Loss - EUR | - | -745 | 790 | -4.930 | -3.206 | -2.073 | -2.857 | 86 | -3.379 | -2.675 |
| Employees | - | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 1 |
Check the financial reports for the company - C.e.s. Elfarma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 256 | 252 | 247 | 243 | 238 | 233 | 233 | 36 | 0 |
| Current Assets | - | 6.629 | 15.043 | 18.900 | 23.491 | 28.453 | 30.023 | 20.428 | 11.043 | 9.930 |
| Inventories | - | 153 | 1.587 | 1.515 | 3.701 | 3.640 | 5.162 | 2.790 | 505 | 747 |
| Receivables | - | 3.516 | 13.275 | 16.804 | 19.450 | 24.478 | 24.565 | 17.475 | 10.153 | 8.520 |
| Cash | - | 2.961 | 182 | 580 | 340 | 335 | 296 | 163 | 385 | 664 |
| Shareholders Funds | - | -701 | 101 | -4.831 | -7.944 | -9.866 | -12.505 | -12.458 | -15.799 | -18.386 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 7.586 | 15.194 | 23.978 | 31.677 | 38.557 | 42.760 | 33.119 | 26.878 | 28.316 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - C.e.s. Elfarma Srl